{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:57:26Z","timestamp":1791989846953,"version":"4.4.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["GCC[2023]042"],"award-info":[{"award-number":["GCC[2023]042"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M711697"],"award-info":[{"award-number":["2022M711697"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20259"],"award-info":[{"award-number":["U20A20259"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21991081"],"award-info":[{"award-number":["21991081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22201141"],"award-info":[{"award-number":["22201141"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biomaterials.2025.123378","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:04:28Z","timestamp":1745607868000},"page":"123378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["\u03b1-Synuclein targeted therapy with multiple pathological improvement for Parkinson's disease by macrocyclic amphiphile nanomedicine"],"prefix":"10.1016","volume":"322","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3683-7956","authenticated-orcid":false,"given":"Jian-Mei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Xian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Bin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun-Cheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0765-5427","authenticated-orcid":false,"given":"Dong-Sheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Hai","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biomaterials.2025.123378_bib1","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson's disease: a special essay on the 200th anniversary of the shaking palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biomaterials.2025.123378_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson's disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123378_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","article-title":"Understanding dopaminergic cell death pathways in Parkinson disease","volume":"90","author":"Michel","year":"2016","journal-title":"Neuron"},{"issue":"8811","key":"10.1016\/j.biomaterials.2025.123378_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0140-6736(92)90457-E","article-title":"Dopamine, tremor, and Parkinson's disease","volume":"340","author":"Hirsch","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2025.123378_bib5","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123378_bib6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson's disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123378_bib7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/14656566.2016.1149163","article-title":"New and emerging medical therapies in Parkinson's disease","volume":"17","author":"Lotia","year":"2016","journal-title":"Expet Opin. Pharmacother."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123378_bib8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s40263-016-0386-8","article-title":"Novel levodopa formulations for Parkinson's disease","volume":"30","author":"Freitas","year":"2016","journal-title":"CNS Drugs"},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123378_bib9","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.3390\/jcm12134427","article-title":"Levodopa-induced dyskinesias in Parkinson's disease: an overview on pathophysiology, clinical manifestations, therapy management strategies and future directions","volume":"12","author":"Biase","year":"2023","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","article-title":"Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management","volume":"23","author":"O'Sullivan","year":"2009","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123378_bib11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nrd.2018.136","article-title":"Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs","volume":"17","author":"Charvin","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123378_bib12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00702-023-02708-4","article-title":"Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson's disease?","volume":"130","author":"Pirto\u0161ek","year":"2023","journal-title":"J. Neural Transm."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123378_bib13","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/mds.26354","article-title":"Disease-modifying strategies for Parkinson's disease","volume":"30","author":"Kalia","year":"2015","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123378_bib14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/mds.26332","article-title":"Basic science breaks through: new therapeutic advances in Parkinson's disease","volume":"30","author":"Brundin","year":"2015","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123378_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40265-019-01104-1","article-title":"Targeting \u03b1-synuclein in Parkinson's disease: progress towards the development of disease-modifying therapeutics","volume":"79","author":"Savitt","year":"2019","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","article-title":"Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson's disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Trends Neurosci."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123378_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-Synuclein misfolding and aggregation: implications in Parkinson's disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"BBA-PROTEINS PROTEOM"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123378_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5321","key":"10.1016\/j.biomaterials.2025.123378_bib19","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123378_bib20","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024109","article-title":"Genetics of synucleinopathies","volume":"8","author":"Nussbaum","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123378_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ana.24066","article-title":"Lewy body extracts from Parkinson disease brains trigger \u03b1-synuclein pathology and neurodegeneration in mice and monkeys","volume":"75","author":"Recasens","year":"2014","journal-title":"Ann. Neurol."},{"issue":"50","key":"10.1016\/j.biomaterials.2025.123378_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba3967","article-title":"Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson's disease","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123378_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202310404","article-title":"Alpha-synuclein oligomers driven T1-T2 switchable nanoprobes for early and accurate diagnosis of Parkinson's disease","volume":"36","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123378_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.26562","article-title":"Lysosomal dysfunction and alpha-synuclein aggregation in Parkinson's disease: diagnostic links","volume":"31","author":"Moors","year":"2016","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mds.26477","article-title":"Autophagy and alpha-Synuclein: relevance to Parkinson's disease and related synucleopathies","volume":"31","author":"Xilouri","year":"2016","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123378_bib26","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","article-title":"Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson's disease","volume":"13","author":"Emin","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-Synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","article-title":"\u03b1-Synuclein in synaptic function and dysfunction","volume":"46","author":"Sharma","year":"2023","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrn3887","article-title":"Spreading of pathology in neurodegenerative diseases: a focus on human studies","volume":"16","author":"Brettschneider","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123378_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrn2786","article-title":"Prion-like mechanisms in neurodegenerative diseases","volume":"11","author":"Frost","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123378_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123378_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn.2016.13","article-title":"A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration","volume":"17","author":"Walsh","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123378_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202200192","article-title":"Tailoring a nanochaperone to regulate \u03b1-synuclein assembly","volume":"61","author":"Wu","year":"2022","journal-title":"Angew. Chem., Int. Ed."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123378_bib34","first-page":"315","article-title":"Inhibition of amyloid fibrillation by small molecules and nanomaterials: strategic development of pharmaceuticals against amyloidosis, protein Pept","volume":"26","author":"Sharma","year":"2019","journal-title":"Letture"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/tcr.202300282","article-title":"Navigating \u03b1-synuclein aggregation inhibition: methods, mechanisms, and molecular targets","volume":"24","author":"Galkin","year":"2023","journal-title":"Chem. Rec."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123378_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202306760","article-title":"Bioorthogonal aptamer-ATTEC conjugates for degradation of alpha-synuclein via autophagy-lysosomal pathway","volume":"20","author":"Liao","year":"2024","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123378_bib37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123378_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biomaterials.2025.123378_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.718188","article-title":"Green tea polyphenol epigallocatechin-gallate in amyloid aggregation and neurodegenerative diseases","volume":"15","author":"Fernandes","year":"2021","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/1673-5374.290879","article-title":"Potential therapeutic effects of polyphenols in Parkinson's disease: in vivo and in vitro pre-clinical studies","volume":"16","author":"Giuliano","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123378_bib41","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41565-018-0179-y","article-title":"Graphene quantum dots prevent \u03b1-synucleinopathy in Parkinson's disease","volume":"13","author":"Kim","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123378_bib42","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1021\/acs.chemmater.1c01947","article-title":"Inhibition of amyloid aggregation and toxicity with janus iron oxide nanoparticles","volume":"33","author":"Andrikopoulos","year":"2021","journal-title":"Chem. Mater."},{"issue":"15","key":"10.1016\/j.biomaterials.2025.123378_bib43","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/cbic.201900224","article-title":"Coordination of platinum to \u03b1-synuclein inhibits filamentous aggregation in solution","volume":"20","author":"Pan","year":"2019","journal-title":"Chembiochem"},{"issue":"24","key":"10.1016\/j.biomaterials.2025.123378_bib44","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1039\/C9NR02407G","article-title":"Amphiphilic surface chemistry of fullerenols is necessary for inhibiting the amyloid aggregation of alpha-synuclein NACore","volume":"11","author":"Sun","year":"2019","journal-title":"Nanoscale"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123378_bib45","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1021\/acsabm.0c01021","article-title":"Modulation of amyloid protein fibrillation by synthetic polymers: recent advances in the context of neurodegenerative diseases","volume":"3","author":"Ghosh","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123378_bib46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00396-020-04710-8","article-title":"Polymer materials as promoters\/inhibitors of amyloid fibril formation","volume":"299","author":"Holubov\u00e1","year":"2021","journal-title":"Colloid Polym. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123378_bib47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13024-023-00675-8","article-title":"Peptide-based approaches to directly target alpha-synuclein in Parkinson's disease","volume":"18","author":"Allen","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123378_bib48","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1002\/anie.201906908","article-title":"Peptide-based molecular strategies to interfere with protein misfolding, aggregation, and cell degeneration","volume":"59","author":"Armiento","year":"2020","journal-title":"Angew. Chem., Int. Ed."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123378_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202105711","article-title":"Self-catalytic small interfering RNA nanocarriers for synergistic treatment of neurodegenerative diseases","volume":"34","author":"Ji","year":"2022","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123378_bib50","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acsnano.1c08473","article-title":"Intranasal administration of self-oriented nanocarriers based on therapeutic exosomes for synergistic treatment of Parkinson's disease","volume":"16","author":"Peng","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123378_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121949","article-title":"Exosomes based strategies for brain drug delivery","volume":"293","author":"Rehman","year":"2023","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123378_bib52","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1021\/acsnano.2c12840","article-title":"Multiscale NIR-II imaging-guided brain-targeted drug delivery using engineered cell membrane nanoformulation for Alzheimer's disease therapy","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123378_bib53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41557-018-0164-y","article-title":"Heteromultivalent peptide recognition by co-assembly of cyclodextrin and calixarene amphiphiles enables inhibition of amyloid fibrillation","volume":"11","author":"Xu","year":"2019","journal-title":"Nat. Chem."},{"issue":"24","key":"10.1016\/j.biomaterials.2025.123378_bib54","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1021\/acs.accounts.3c00585","article-title":"Molecular recognition with macrocyclic receptors for application in precision medicine","volume":"56","author":"Pan","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123378_bib55","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.31635\/ccschem.020.202000561","article-title":"Coassembly of macrocyclic amphiphiles for anti-\u03b2-amyloid therapy of Alzheimer's disease","volume":"3","author":"Pan","year":"2020","journal-title":"CCS Chem."},{"issue":"40","key":"10.1016\/j.biomaterials.2025.123378_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202104310","article-title":"A supramolecular antidote to macromolecular toxins prepared through coassembly of macrocyclic amphiphiles","volume":"33","author":"Pan","year":"2021","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123378_bib57","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1038\/s41467-022-31986-x","article-title":"A facile way to construct sensor array library via supramolecular chemistry for discriminating complex systems","volume":"13","author":"Tian","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123378_bib58","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1039\/b501472g","article-title":"Arginine magic with new counterions up the sleeve","volume":"3","author":"Nishihara","year":"2005","journal-title":"Org. Biomol. Chem."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123378_bib59","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/anie.202011185","article-title":"An amphiphilic sulfonatocalix[5]arene as a novel activator for membrane transport of lysine-rich peptides and proteins","volume":"60","author":"Pan","year":"2020","journal-title":"Angew. Chem., Int. Ed."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123378_bib60","doi-asserted-by":"crossref","first-page":"885","DOI":"10.31635\/ccschem.022.202201859","article-title":"CASTING: a potent supramolecular strategy to cytosolically deliver STING agonist for cancer immunotherapy and SARS-CoV-2 vaccination","volume":"5","author":"Wu","year":"2023","journal-title":"CCS Chem."},{"issue":"41","key":"10.1016\/j.biomaterials.2025.123378_bib61","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1039\/D0CC01800G","article-title":"A host-guest ATP responsive strategy for intracellular delivery of phosphopeptides","volume":"56","author":"Han","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biomaterials.2025.123378_bib62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jconrel.2020.05.008","article-title":"A host-guest drug delivery nanosystem for supramolecular chemotherapy","volume":"324","author":"Hu","year":"2020","journal-title":"J. Control. Release"},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123378_bib63","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1021\/jacs.8b02331","article-title":"Biomarker displacement activation: a general host-guest strategy for targeted phototheranostics in vivo","volume":"140","author":"Gao","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib64","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1039\/C6CC09079F","article-title":"A self-assembled white-light-emitting system in aqueous medium based on a macrocyclic amphiphile","volume":"53","author":"Geng","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biomaterials.2025.123378_bib65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2116\/analsci.24.207","article-title":"Effect of cyclodextrins on saccharide sensing function of a fluorescent phenylboronic acid in water","volume":"24","author":"Ozawa","year":"2008","journal-title":"Anal. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123378_bib66","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/chem.200400905","article-title":"Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules","volume":"11","author":"Falvey","year":"2005","journal-title":"Chem. Eur J."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123378_bib67","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/anie.201309583","article-title":"Chemosensing ensembles for monitoring biomembrane transport in real time","volume":"53","author":"Ghale","year":"2014","journal-title":"Angew. Chem., Int. Ed."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123378_bib68","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1111\/bph.15149","article-title":"Metformin mitigates gastrointestinal radiotoxicity and radiosensitises P53 mutation colorectal tumours via optimising autophagy","volume":"177","author":"Chen","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123378_bib69","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/bph.14110","article-title":"Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis in Parkinson's disease models both in vitro and in vivo","volume":"175","author":"Peng","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123378_bib70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/bph.15961","article-title":"Icariside II preconditioning evokes robust neuroprotection against ischaemic stroke, by targeting Nrf2 and the OXPHOS\/NF-\u03baB\/ferroptosis pathway","volume":"180","author":"Gao","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/ars.2019.7825","article-title":"Neuroprotective effects of trilobatin, a novel naturally occurring Sirt3 agonist from lithocarpus polystachyus rehd., mitigate cerebral ischemia\/reperfusion injury: involvement of TLR4\/NF-\u03baB and Nrf2\/Keap-1 signaling","volume":"33","author":"Gao","year":"2020","journal-title":"Antioxid. Redox Signal."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123378_bib72","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1002\/1521-3773(20010917)40:18<3411::AID-ANIE3411>3.0.CO;2-D","article-title":"Nucleophilic trapping of pi-allylpalladium intermediates generated by carbopalladation of bicyclopropylidene: a novel three-component reaction cyclopropyl building blocks in organic synthesis","volume":"40","author":"N\u00fcske","year":"2001","journal-title":"Angew. Chem., Int. Ed."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123378_bib73","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1111\/bph.15502","article-title":"Scorpion venom heat-resistant synthesized peptide ameliorates 6-OHDA-induced neurotoxicity and neuroinflammation: likely role of Na(v) 1.6 inhibition in microglia","volume":"178","author":"Li","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123378_bib74","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1111\/bph.15145","article-title":"6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata","volume":"177","author":"Vegas-Su\u00e1rez","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biomaterials.2025.123378_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101695","article-title":"\u03b1-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo","volume":"37","author":"Van Laar","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biomaterials.2025.123378_bib76","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/DDDT.S130514","article-title":"Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease","volume":"11","author":"Ganguly","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123378_bib77","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1089\/ars.2017.7145","article-title":"Nicotinamide adenine dinucleotide metabolism and neurodegeneration","volume":"28","author":"Pehar","year":"2018","journal-title":"Antioxid. Redox Signal."},{"issue":"7901","key":"10.1016\/j.biomaterials.2025.123378_bib78","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41586-022-04511-9","article-title":"Methane formation driven by reactive oxygen species across all living organisms","volume":"603","author":"Ernst","year":"2022","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.biomaterials.2025.123378_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101316","article-title":"Facet-dependent biodegradable Mn3O4 nanoparticles for ameliorating Parkinson's disease","volume":"10","author":"Xu","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123378_bib80","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/jacs.8b11856","article-title":"Chiral molecule-mediated porous CuxO nanoparticle clusters with antioxidation activity for ameliorating Parkinson's disease","volume":"141","author":"Hao","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123378_bib81","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1039\/D2NR04534F","article-title":"Chiral Se@CeO2 superparticles for ameliorating Parkinson's disease","volume":"15","author":"Liu","year":"2023","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123378_bib82","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","article-title":"Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123378_bib83","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1002\/anie.202010981","article-title":"Chemical tagging of protein lipoylation","volume":"60","author":"Tang","year":"2021","journal-title":"Angew. Chem., Int. Ed."},{"issue":"6586","key":"10.1016\/j.biomaterials.2025.123378_bib84","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"issue":"30","key":"10.1016\/j.biomaterials.2025.123378_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202404576","article-title":"Black phosphorus nanosheets protect neurons by degrading aggregative \u03b1-syn and clearing ROS in Parkinson's disease","volume":"36","author":"He","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123378_bib86","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-019-0349-x","article-title":"Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway","volume":"15","author":"Park","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biomaterials.2025.123378_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122971","article-title":"Responsive plasmonic hybrid nanorods enables metabolism reprogramming via cuproptosis-photothermal combined cancer therapy","volume":"315","author":"Xie","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123378_bib88","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijbiomac.2020.06.274","article-title":"Copper and iron ions accelerate the prion-like propagation of \u03b1-synuclein: a vicious cycle in Parkinson's disease","volume":"163","author":"Li","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123378_bib89","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s12035-018-1274-7","article-title":"Copper increases brain oxidative stress and enhances the ability of 6-hydroxydopamine to cause dopaminergic degeneration in a rat model of Parkinson's disease","volume":"56","author":"Cruces-Sande","year":"2019","journal-title":"Mol. Neurobiol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225002972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225002972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:55:26Z","timestamp":1762242926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225002972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":89,"alternative-id":["S0142961225002972"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123378","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Synuclein targeted therapy with multiple pathological improvement for Parkinson's disease by macrocyclic amphiphile nanomedicine","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123378"}}